Logo-jcvtr

Submitted: 22 Apr 2025
Revision: 22 Sep 2025
Accepted: 02 Jul 2026
ePublished: 25 Aug 2026
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2026;18(3): 211-218.
doi: 10.34172/jcvtr.33582
  Abstract View: 24
  PDF Download: 19

Original Article

Prevalence and Determinant Factors of Metabolic Syndrome in the Azar-Cohort Population

Somayeh Borjibezhad 1,2 ORCID logo, Fariba Heidari 2,3* ORCID logo, Saeed Dastgiri 4 ORCID logo, Elnaz Faramarz 1 ORCID logo

1 Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Department of Community and Family Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3 Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4 Tabriz Health Services Management Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Author: Fariba Heidari, Email: fheidari@tbzmed.ac.ir, Email: Fariba_heidari@hotmail.com

Abstract

Introduction: Metabolic syndrome (MetS) is a global public health issue with notable regional variations. This study aimed to determine the prevalence and determinant factors of metabolic syndrome in a large population-based cohort in the North-West of Iran.

Methods: This cross-sectional study involved 14,906 adult participants aged 35 to 70 years from the Azar-cohort study. Data on sociodemographic and lifestyle characteristics, and medication history were collected through face-to-face interviews by trained interviewers. Biochemical laboratory tests and medical examinations were conducted. Population of the Shabestar County who met the inclusion criteria and had informed consent were included. MetS was defined by the National Cholesterol Education Program’s Adult Treatment Panel III report (ATP III) criteria. To assess the determinant factors we applied logistic regression analysis.

Results: The prevalence of metabolic syndrome was 34%. On average, the MetS group was significantly older and included more women. Waist-to-hip ratio (W/H), was significantly higher in MetS group than in the non-MetS group (0.94 vs. 0.88, P<0.001). In univariate analysis, subjects with very high wealth score index (WSI) quintile had lower odds of MetS compared to the very low quintile (OR=0.79, 95% CI: 0.71-0.88). After adjustment for potential confounding factors, the body mass index (BMI), physical activity level, and smoking status were significantly related to the MetS.

Conclusion: It seems that MetS is relatively high in the Azar-Cohort population, which calls for interventional programs to reduce the burden and future complications. Regarding the non-modifiable factors, it seems vital to tailor interventions to high-risk groups.


First Name
Last Name
Email Address
Comments
Security code


Abstract View: 25

Your browser does not support the canvas element.

PDF Download: 19

Your browser does not support the canvas element.